Overview
- 26 inspections across 25 sites are on record.
- 17 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-11-30.
At a glance
Inspections
26
Sites
25
Observations
17
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jeremy Veenstra-Vanderweele, M.D. | 30 Nov 2023 | Human Drugs | |
| Institute for In Vitro Sciences, Inc. | 21 Aug 2009 | ||
| Aplicare Incorporated | 7 Aug 2009 | ||
| Wanda Pool, DVM | 17 Jul 2009 | ||
| U.S. Food and Drug Administration (FDA) Institutional Review Board (IRB) | 30 Jun 2009 |
Sites inspected
Jeremy Veenstra-Vanderweele, M.D.White Plains, United States1 insp.
Institute for In Vitro Sciences, Inc.Gaithersburg, United States1 insp.
Aplicare IncorporatedPrichard, United States1 insp.
Wanda Pool, DVMCentreville, United States1 insp.
U.S. Food and Drug Administration (FDA) Institutional Review Board (IRB)Silver Spring, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Patric C Klotzbuecher4 shared
Dawn M Collins2 shared
Elvis D Morton2 shared
Roberto A Dookhan1 shared
Daniel R Azar1 shared
Margaret H Waters1 shared
Ernest Bizjak1 shared
David K Glasgow1 shared
Monique-Rac Lester1 shared
James T Mccoy1 shared
Full investigator report
Get the verbatim findings behind Lakisha M Williams' 17 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site